Treatment for First-Episode Schizophrenia

Completed · Phase 4

Conditions studied: Schizophrenia

In brief

This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.

Key facts

Study ID

NCT00000374

Run by

Northwell Health

People needed

125

Starts

1998-09-01

Expected to finish

2007-05-01

Last updated by the study team

2012-01-13

Who can join

Age: 16 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• First episode schizophrenia, schizophreniform disorder or schizoaffective disorder

You may not qualify if…

• Prior treatment with antipsychotic medications.

Where it is running

• Hillside Hospital — Glen Oaks, New York, United States
• Bronx-Lebanon Hospital Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.